Director
DIN: 07705867
Usha Bhutani is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at ELDER BIOSCIENCE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07705867.Usha Bhutani has previously been associated with 1 company in roles such as Additional Director.Usha Bhutani is currently involved in 2 different roles. Their most recent position is with INTERNATIONAL DRUGS AND PHARMACEUTICALS LIMITED as a Director. The first company Usha Bhutani was appointed to as a director was ELDER BIOSCIENCE PRIVATE LIMITED. Usha Bhutani has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Usha Bhutani is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at ELDER BIOSCIENCE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07705867.Usha Bhutani has previously been associated with 1 company in roles such as Additional Director.Usha Bhutani is currently involved in 2 different roles. Their most recent position is with INTERNATIONAL DRUGS AND PHARMACEUTICALS LIMITED as a Director. The first company Usha Bhutani was appointed to as a director was ELDER BIOSCIENCE PRIVATE LIMITED. Usha Bhutani has a status of Deactivated. Please verify the details for any specific requirements or conditions.
3
Female
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
1y 2m 7 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ELDER BIOSCIENCE PRIVATE LIMITED | Director | 31-Dec-2020 |
| INTERNATIONAL DRUGS AND PHARMACEUTICALS LIMITED | Director | 04-Jan-2023 |
| INTERNATIONAL DRUGS AND PHARMACEUTICALS LIMITED | Individual Promoter | 04-Jan-2023 |